FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants

Bracco Invests in GMP Manufacturing Facility for Cell Therapy Product Facility upgrades support clinical-grade manufacturing of Bracco’s microbubble-based cell selection and activation technology. GMP readiness expected mid-2027.

BubbleGen™ Early Access Program Developed by Bracco, BubbleGen™ microbubbles build on more than two decades of use in diagnostic imaging and offer a bead-free alternative to traditional magnetic approaches.

Bracco Imaging Earns Second Consecutive EcoVadis Platinum Medal with Record Sustainability Score Recognition reflects Bracco Imaging’s top-tier EcoVadis performance and strengthened sustainability data, governance and procurement practices.

Cell Therapy Built on Bracco’s lipid microbubble technology, BubbleGen™ enables simpler, bead-free, and column-free cell selection that integrates seamlessly into cell therapy research workflows.

BubbleGen Cell Selection Products Microbubble-based cell selection technology for cell therapy research.

BubbleGen CD3+ Cell Selection Kit The BubbleGen™ CD3+ Cell Selection Kit provides a ready-to-use solution for enrichment of CD3+ T cells using Bracco's BubbleGen™ microbubble technology.

BubbleGen Cell Separators The BubbleGen™ Cell Separators kit provides 10 cell separators to be used in conjunction with our BubbleGen™ cell selection kits.

Cell Therapy Resources Supporting successful implementation of BubbleGen™ workflows.

Celltherapy order form Order BubbleGen™ Cell Selection Research Products